[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hims & Hers Health (HIMS) Form 4: Chief Commercial Officer Michael Chi executed and sold option shares on 23-24 Jul 2025 under a Rule 10b5-1 plan adopted 4 Mar 2025.

• Option exercises: 15,850 Class A shares exercised at strike prices of $5.01, $6.82 and $11.53.
• Sales: 15,850 shares sold almost immediately at weighted prices of ~$56–57.52, realising a gross spread of >$45 per share.
• Post-trade holdings: Direct ownership remains 278,654 shares. Derivative holdings (vested/unvested options) fall to 192,942.
• Options stem from 2022-23 grants that vest monthly over four years; earliest expiry 24 Feb 2032.

No change to total common stock held, but the executive monetised ~6% of his prior common share position while retaining a sizeable stake and option pool.

Positive

• None.

Negative

• Insider disposed 15,850 shares at significant premium prices, which may be viewed as a bearish sentiment despite the 10b5-1 plan.

Insights

Securities Analyst

TL;DR: Pre-planned option exercise & full sale; neutral-to-slightly negative sentiment signal.

The CCO converted low-strike options into 15,850 shares and sold the entire lot at >$56, pocketing a sizable gain. Although sales were executed under a 10b5-1 plan—which dilutes signalling value—the fact that 100% of the exercised shares were disposed at multi-year highs can be interpreted as mild profit-taking. Remaining ownership (278.7k shares plus 192.9k options) indicates continued economic alignment, limiting downside perception. From a valuation view, the transaction is immaterial to float but may pressure near-term sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Chi Michael

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/23/2025		M(1)		12,600	A	$5.01	291,254	D
Class A Common Stock	07/23/2025		M(1)		900	A	$6.82	292,154	D
Class A Common Stock	07/23/2025		M(1)		250	A	$11.53	292,404	D
Class A Common Stock	07/23/2025		S(1)		13,750	D	$56	278,654	D
Class A Common Stock	07/24/2025		M(1)		2,100	A	$5.01	280,754	D
Class A Common Stock	07/24/2025		S(1)		2,100	D	$57.52	278,654	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.01	07/23/2025		M(1)			12,600	(2)	02/24/2032	Class A Common Stock	12,600	$0	195,042	D
Stock Option (right to buy)	$6.82	07/23/2025		M(1)			900	(3)	08/10/2032	Class A Common Stock	900	$0	124,362	D
Stock Option (right to buy)	$11.53	07/23/2025		M(1)			250	(4)	03/01/2033	Class A Common Stock	250	$0	49,606	D
Stock Option (right to buy)	$5.01	07/24/2025		M(1)			2,100	(2)	02/24/2032	Class A Common Stock	2,100	$0	192,942	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.

2. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on March 24, 2022, and 1/48th of the options vesting monthly thereafter.

3. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting on September 10, 2022, and 1/48th of the options vesting monthly thereafter.

4. The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	07/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many HIMS shares did the CCO sell?

Michael Chi sold 15,850 Class A shares on 23-24 Jul 2025.

At what prices were the HIMS shares sold?

Shares were sold at $56.00 and $57.52 per share.

Did the CCO retain any additional shares after the transaction?

Yes. He still directly owns 278,654 common shares following the sale.

Were these transactions part of a pre-arranged plan?

Yes, all trades were executed under a Rule 10b5-1 plan adopted 4 Mar 2025.

How many options does the CCO still hold?

After the exercises, he retains 192,942 option shares with expiries between 2032-2033.